Skip to main content

Table 1 Patient characteristics

From: Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response

Patient Gender/Age Prior Therapies Surgerya Histology Tumor stage Performance statusc
1 F/78 none upper bilobectomy adenocarcinoma IIIA 0
2 F/47 none lobectomy squamous-cell carcinoma IB 0
3 M/65 none lobectomy large-cell carcinoma IIA 0
4 b M/77 none lobectomy adenocarcinoma IB 0
  1. aall patients received standard systematic hilar/mediastinal lymphadenectomy
  2. bpatient withdrew by choice before the treatment phase
  3. cEastern Cooperative Oncology Group (ECOG) scale